Artificial Intelligence (AI) is becoming a useful tool in healthcare around the world. In the United States, hospitals and healthcare centers use AI to improve patient care, lower paperwork, and make things run more smoothly. But as AI use grows, people worry more about safety, privacy, data quality, and being responsible for the results. In Europe, the European Union (EU) has made a law called the EU Artificial Intelligence Act (AI Act). This law makes strict rules for AI systems that are considered high-risk, including those used in healthcare.
Though this law mainly applies in the EU, it can still affect U.S. healthcare providers. This is especially true for those working with European partners or wanting to work internationally. Knowing these rules can help U.S. healthcare leaders get ready for similar rules and add good practices into their AI systems, like automated phone answering systems that connect patients with care.
This article talks about the main rules of the EU AI Act related to healthcare AI. It also covers the challenges of these new rules and how AI can help automate work to improve efficiency. By understanding these things, U.S. healthcare groups can better use AI safely while protecting data, being clear, and following ethical rules.
The EU AI Act, which started in August 2024, sorts AI systems by risk levels: unacceptable, high, limited, and minimal. Many AI uses in healthcare are labeled high-risk because they affect patients’ health and treatment. This includes AI used in diagnosis, treatment advice, patient profiling, and tasks like billing or scheduling.
High-risk AI systems must follow strict rules to stop harm, protect patient data, and keep the system clear and reliable. Developers and providers, including those outside the EU who sell AI in the EU, must follow these rules.
The main rules in the Act include:
The EU AI Act is backed by rules like ISO/IEC 42001 for AI risk management and projects like the European Health Data Space (EHDS), which helps use health data safely while keeping privacy. These rules raise the standards for being responsible and safe with AI. U.S. healthcare leaders should think about adding these ideas to their plans.
Risk management is very important in the EU AI Act for high-risk systems. Daniela Deflorio explains how risk checking and managing fit with Good Clinical Practice (GCP) rules. GCP is known worldwide for quality in clinical trials, and it also fits well with AI in clinical and admin healthcare settings.
In simple terms, risk management means healthcare AI must find errors or bias and have ways to reduce their effects. For example, AI tools that diagnose must be tested to avoid wrong positive or negative results that could cause misdiagnoses. Developers and healthcare places must keep careful records of these tests.
For U.S. healthcare leaders, having good risk management means creating teams with doctors, IT staff, and compliance officers to keep checking AI use. This review should look at clinical accuracy, ethical questions, and cyber risks that could harm patient data.
Healthcare AI uses a lot of sensitive patient data. The EU AI Act, along with the General Data Protection Regulation (GDPR), sets strict rules on data privacy and control. AI must handle personal health data carefully to prevent unauthorized access or misuse.
In the U.S., the Health Insurance Portability and Accountability Act (HIPAA) controls healthcare data privacy. However, the EU’s stricter AI rules serve as a model to improve data protection beyond HIPAA, mainly because of AI’s special risks. For example, some AI models learn continuously after they are deployed. This makes managing consent and protecting privacy harder.
Healthcare leaders can learn from the EU by using better data encryption, making data anonymous, and doing regular checks to find privacy problems early. They also need clear rules for keeping data and using it again, balancing AI progress with respecting patient rights.
A main rule of the EU AI Act is to keep humans overseeing AI decisions, especially in healthcare. This means AI should not work alone without human review and the chance to override its decisions.
Human oversight is important because AI can sometimes make biased or wrong outputs. For example, training data might not include enough minority patient groups. This can cause less accurate advice for those groups. Without human checks, biased decisions can harm patients.
In clinics, U.S. health leaders should use AI as help for decisions, not as a replacement for doctors’ judgment. Staff should learn to understand AI results, check if they make sense, and step in when needed. This makes care safer and helps build trust in AI for doctors and patients.
Being clear and open is important for responsible AI use. The EU AI Act asks for detailed papers explaining how AI makes decisions, which data was used for training, and what limits and risks exist.
U.S. healthcare managers and IT staff need to work closely with AI sellers to get these documents and share them with all staff who need them. Transparency helps check AI performance and spot problems or ethical issues before patients are affected.
Also, telling patients when AI is part of their care helps keep things open and supports informed consent. Knowing if a system uses AI helps patients understand and agree to safer and fairer care.
Adaptive AI can change and improve after it is put to use. This creates new challenges, as Yves Saint James Aquino and his team explain. Unlike normal medical devices, adaptive AI needs ongoing checks to stay safe and work well. This makes it harder to control.
In the U.S., this means healthcare managers and IT staff should get ready for constant monitoring rather than one-time approval for AI. They must work closely with software creators, risk experts, and clinical staff to watch how the AI performs, record changes, and report problems.
Europe is working on rules where regulators, professional groups, and healthcare providers team up to supervise changes in adaptive AI. U.S. healthcare groups can learn from this by building teams from different fields to keep AI legal and safe.
AI also helps in healthcare administrative work, beyond clinical decision making. Automation in front-office tasks like phone answering, scheduling, and billing uses AI tools to save work and boost accuracy.
For example, Simbo AI offers AI-driven phone answering services. These systems can handle simple patient calls, remind about appointments, and sort questions so staff can focus on harder work. This helps communication run smoother, cuts wait times, and improves patient experience.
The EU AI Act also applies to these operational AI systems if they are high-risk because they affect patient access and data use. Healthcare owners and IT leaders need to make sure these AI tools meet rules about transparency, security, and data quality.
In billing, AI can study big data sets to find signs of fraud or mistakes. Research by the European Commission shows AI can cut false alarms in fraud checks and create compliance reports automatically. This not only saves money but builds trust with payers and regulators.
By automating work, U.S. healthcare providers can cut costs, reduce errors, and work more efficiently. But they must use AI carefully, following data rules and ethics to keep patient trust and stay within the law.
Although the EU AI Act mainly controls AI in the European Union, its influence is growing worldwide as rules get stricter and healthcare moves toward global standards. U.S. healthcare leaders should think about changing their AI rules to match these high standards for safety and openness.
It is important to train staff on AI ethics, data privacy, and system limits. Working closely with AI sellers to get full documents and testing beyond local demands protects healthcare groups legally and helps patients.
Voluntary groups like the AI Pact, supported by the European Commission, are early examples of healthcare providers and developers agreeing to meet high AI standards. U.S. providers can make similar internal rules to prepare for future laws that may look like the EU’s.
The EU AI Act has detailed and strict rules for healthcare AI systems. These focus on safety, openness, human control, and data fairness. For medical practices in the U.S., knowing these rules helps prepare for changes in regulations and improve AI-driven healthcare, whether in clinical tools or administrative automation like Simbo AI offers. Following these rules helps keep patients safe, protects data, and improves how healthcare runs as AI grows fast.
The EU AI Act requires healthcare AI tools to meet criteria such as risk assessment, cybersecurity measures, human oversight, transparency, and post-market monitoring to ensure patient safety and data quality.
Risk management in healthcare AI focuses on identifying, assessing, and mitigating potential risks throughout the AI system’s lifecycle, ensuring compliance with regulations and safeguarding patient health.
Healthcare AI systems require vast amounts of personal data, raising concerns about data privacy and security, especially if breaches lead to unauthorized access or misuse.
Human oversight is crucial in healthcare AI to review and correct AI decisions, reducing the risks of biased outputs and ensuring accountability in clinical settings.
Biases in AI can lead to unfair treatment recommendations, exacerbating existing healthcare inequalities and affecting patient outcomes by perpetuating stereotypes found in training data.
Key regulatory frameworks for managing AI risks include the EU AI Act, ISO/IEC 42001, and the NIST AI Risk Management Framework, which aim to provide standardized protocols for safe AI deployment.
Inaccurate AI outputs can lead to misdiagnoses, inappropriate treatments, and other potentially harmful consequences, underscoring the need for robust testing and validation protocols.
Data quality is essential for AI systems as accurate, comprehensive, and unbiased data lead to reliable outputs, enhancing the overall effectiveness of AI in healthcare.
Organizations can address skill gaps by investing in specialized training for staff, fostering a culture of continuous learning, and collaborating with external experts to ensure effective AI adoption.
Long-term sustainability concerns include the environmental impact of energy-intensive AI models, potential job disruptions due to automation, and growing digital divides, necessitating careful consideration in AI deployment.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
